| Literature DB >> 15234467 |
Joelle M van der Walt1, Yulia A Dementieva, Eden R Martin, William K Scott, Kristin K Nicodemus, Charles C Kroner, Kathleen A Welsh-Bohmer, Ann M Saunders, Allen D Roses, Gary W Small, Donald E Schmechel, P Murali Doraiswamy, John R Gilbert, Jonathan L Haines, Jeffery M Vance, Margaret A Pericak-Vance.
Abstract
We examined the association of mtDNA variation with Alzheimer disease (AD) risk in Caucasians (989 cases and 328 controls) testing the effect of individual haplogroups and single nucleotide polymorphisms (SNPs). Logistic regression analyses were used to assess risk of haplogroups and SNPs with AD in both main effects and interaction models. Males classified as haplogroup U showed an increase in risk (OR = 2.30; 95% CI, 1.03-5.11; P = 0.04) of AD relative to the most common haplogroup H, while females demonstrated a significant decrease in risk with haplogroup U (OR = 0.44 ; 95% CI, 0.24-0.80; P = 0.007). Our results were independent of APOE genotype, demonstrating that the effect of mt variation is not confounded by APOE4 carrier status. We suggest that variations within haplogroup U may be involved in AD expression in combination with environmental exposures or nuclear proteins other than APOE.Entities:
Mesh：
Substances：
Year: 2004 PMID： 15234467 DOI： 10.1016/j.neulet.2004.04.051
Source DB: PubMed Journal: Neurosci Lett ISSN： 0304-3940 Impact factor: 3.046